Friday, February 20, 2026
21 C
Bengaluru

Digital Noise to Digital Voice – A 4-Module Workshop for Pharma People

When Covid19 struck for the first time in March 2020, the pharma industry was not ready for the sudden and dramatic changes, that disrupted the healthcare industry completely.

And to deal with the sudden and dramatic changes, professionals in the pharma industry needed awareness, education, and knowledge sharing.

MedicinMan took up this responsibility in partnership with CredoWeb to create “Digital Excellence Pharma Academy” –DEPA and conducted 50+ online sessions with renowned Indian and International healthcare industry influencers as faculty members, from May 2020 to April 2021.

And DEPA1.0 was a great success!

Now is time to learn how to perform marketing and sales activities using the new technology in the New Normal on practice! 

We go into the why, how, and what of doing digital. If you were a Listener till now, you’ll be a Player now!

MedicinMan in partnership with CredoWeb is again coming up with the 2.0 version of our DEPA with international and Indian faculty – Dr. Peter Velev, a medical doctor and pharma industry veteran, Praful Akali, founder and CEO of Medulla Communications and Salil Kallianpur, pharma marketing veteran and digital brand coach.

The workshop sessions will be moderated by Anup Soans, Editor @ MedicinMan to discuss: International and Indian case studies Interactive Q & A sessions

We are launching DEPA 2.0 Workshop with four Modules beginning Saturday, October 30, 2021.

For registration and program details – https://medicinman.net/register-for-depa-2-0/

For any questions and how to join DEPA 2.0 please write to: anupsoans@medicinman.net

Hot this week

India’s Pharma Renaissance: Private Equity at the Helm

Indian pharmaceuticals have long been known as the “pharmacy...

The ₹5 Snack SKU: A Silent Indian Metabolic Crisis

Executive Summary — The Paradox of Scale In the annals...

Sleep Apnea: Apnimed Pill to Replace CPAP Machine?

In India, where urban sleep debt is rising, obesity...

Why the World Still Doesn’t Celebrate Antibiotic Breakthroughs llike Zaynich

When a new cancer drug shows promise, it trends...

From Overuse to Overreaction: Recalibrating India’s C-Section Debate

India’s caesarean section debate is drifting toward polarisation. On one...

Topics

India’s Pharma Renaissance: Private Equity at the Helm

Indian pharmaceuticals have long been known as the “pharmacy...

The ₹5 Snack SKU: A Silent Indian Metabolic Crisis

Executive Summary — The Paradox of Scale In the annals...

Sleep Apnea: Apnimed Pill to Replace CPAP Machine?

In India, where urban sleep debt is rising, obesity...

From Overuse to Overreaction: Recalibrating India’s C-Section Debate

India’s caesarean section debate is drifting toward polarisation. On one...

Sanofi’s Decision not to Renew Paul Hudson as CEO Marks a Structural Shift

In big pharma, leadership changes are rarely impulsive. They...

THE ENCUBE ETHICALS PLAYBOOK: FROM GOA WORKSHOP TO $2BN+ GLOBAL DEAL

How a niche Indian topicals manufacturer outgrew its CDMO...

Indian Pharma: Are Regulatory Gaps From Generics Following Biosimilars?

Transparency, Trust, and the Problem of “Invisible Evidence” in...
spot_img

Related Articles

spot_imgspot_img